Pathophysiological mechanisms linking type 2 diabetes and dementia: Review of evidence from clinical, translational and epidemiological research.
CONCLUSION: Vascular disease, inflammation and impaired brain insulin signaling might occur in T2D and contribute to dementia risk. Evidence from epidemiological studies has not consistently reported associations that could integrate a unified mechanism of disease in humans. Evaluation of the effect of antidiabetic medications and non-pharmacological interventions in dementia prevention in type 2 diabetes is promising but has thus far offered inconsistent results.
PMID: 30648514 [PubMed - as supplied by publisher]
Source: Current Diabetes Reviews - Category: Endocrinology Authors: Bello-Chavolla OY, Antonio-Villa NE, Vargas-Vázquez A, Ávila-Funes JA, Aguilar-Salinas CA Tags: Curr Diabetes Rev Source Type: research
More News: Alzheimer's | Brain | Databases & Libraries | Dementia | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Disability | Endocrinology | Epidemiology | Genetics | Insulin | Metabolic Syndrome | Mitochondrial Disease | Neurology | Pathology | Statistics | Study